Results: 166

Antihipertensivos en pacientes con COVID-19

Rev. chil. cardiol; 39 (1), 2020
En 31 de diciembre del 2019 la Organización Mundial de la Salud fue informada por las autoridades sanitarias chinas de la aparición de casos de neumonía de origen desconocido en la ciudad de Wuhan en China. El 7 de Enero de 2020, científicos chinos identificaron a un nuevo coronavirus (temporalmente ...

Association between Therapeutic Adherence and the Profile of Patients with Resistant Hypertension

Abstract Background: Resistant hypertension (RH) consists of increased blood pressure (BP) despite the use of 3 or more antihypertensives or BP control only when is use of 4 or more antihypertensives. It is fundamental to exclude pseudoresistance, which can be attributed to poor therapeutic adherence. A...

Physical activity and medication in the control of blood pressure: secondary analysis of the Brazilian national health research

AIM: To test the effectiveness of different physical activities (PA) in controlling blood pressure. The dependent variable was controlled and uncontrolled blood pressure (BP). METHODS: This is a secondary analysis of a cross-sectional, observational, descriptive and analytical study from the Brazilian Na...

Rigidez arterial: aplicações clínicas dos conceitos e métodos de avaliação

A caracterização de rigidez arterial é realizada a partir da análise de alterações nas propriedades físicas da parede arterial, entre elas, distensibilidade, complacência e elasticidade. O aumento da rigidez arterial leva a arteriosclerose que está associada ao envelhecimento e a presença dos f...

Uso de treprostinil sistémico en una paciente con hipertensión pulmonar grave, sin respuesta a la máxima terapia disponible

En los pacientes con Hipertensión Arterial Pulmonar (HAP) de alto riesgo, en clase funcional (CF)IV, la terapia específica debe ser combinada y debe incluir una prostaciclina (PGI2) de uso sistémico en espera de trasplante bipulmonar (TBP). En el sistema público la única PGI2 disponible para asociar...

Treatment adherence and frailty syndrome in hypertensive older adults

Rev. Esc. Enferm. USP; 54 (), 2020
Abstract Objective: To analyze the association between adherence to antihypertensive treatment and frailty syndrome in hypertensive older adults. Method: A descriptive, cross-sectional study with a quantitative approach with older adults. The data collection took place between November 2017 and March...

Prácticas autoreferidas para controlar la hipertensión y la diabetes mellitus en adultos mayores de Campinas, Brasil, en tres períodos

Salud colect; 16 (), 2020
RESUMEN El objetivo fue estimar la prevalencia de las prácticas autoreferidas para controlar la hipertensión y la diabetes, con y sin medicamentos, en adultos mayores de Campinas, Brasil, en tres períodos. Se analizaron los datos de las encuestas de salud realizadas en tres períodos: 2001-2002, 2008-...

Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19

Rev Assoc Med Bras (1992); 66 (Suppl 2), 2020
SUMMARY OBJECTIVE Coronavirus disease 2019 (COVID-19) is an emerging health threat caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Previous studies have noted hypertension is associated with increased mortality due to COVID-19; however, it is not clear ...

The effect of Roux-en-Y gastric bypass in the treatment of hypertension and diabetes

Rev. Col. Bras. Cir; 47 (), 2020
ABSTRACT Introduction: obesity has become a public health problem in Brazil and worldwide, due to its high prevalence. It is considered a risk factor for systemic arterial hypertension (SAH) and type 2 diabetes mellitus T2DM. Although lifestyle changes can control and even achieve complete T2DM remissi...